CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Daiichi Sankyo Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Daiichi Sankyo Co Ltd
Daiichi Sankyo Bldg. A/B Kan
3-5-1, Nihombashi Hon-cho
Phone: +81 362251111p:+81 362251111 CHUO-KU, TKY  103-8426  Japan Ticker: 45684568

Business Summary
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20233/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Chairman of the Executive Board, Chief Executive Officer, Representative Dir SunaoManabe 68 4/1/2023 4/1/2012
President, Executive President, Chief Operating Officer, Representative Director HiroyukiOkuzawa 60 4/1/2023 4/1/2018
Chief Financial Officer, Managing Executive Officer KojiOgawa 1/1/2023
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Plexxikon Inc. 91 Bolivar Drive Berkeley CA United States
Ambit Biosciences Corp 11080 Roselle St. SAN DIEGO CA United States
Daiichi Pharmaceutical Co. Ltd. 11 Philips Pkwy Montvale NJ United States
Daiichi Sankyo, Inc. Two Hilton Court Parsippany NJ United States

Business Names
Business Name
4568
Ambit Biosciences Corp
American Regent, Inc.
10 additional Business Names available in full report.

General Information
Number of Employees: 17,435 (As of 3/31/2023)
Outstanding Shares: 1,917,452,190 (As of 12/31/2023)
Shareholders: 73,067
Stock Exchange: TYO
Federal Tax Id: 001059015


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024